PATENT CLAIM ANALYSIS

Application Number: 16080617
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["424", "174100"]

Abstract:
This invention provides a method that combines a checkpoint inhibitor and a glucocorticoid receptor modulator to treat cancer, e.g., a checkpoint inhibitor sensitive cancer.

Claim (Index 8):
The method of  claim 1  wherein the SGRM is a compound having a non-steroidal backbone.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.35
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15942312', '15697878', '15915477', '15500618', '15809759']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7322427362922197
- 35 USC 102 Novelty (BERT): 0.5308904897729838
- Combined Prediction Score: 0.7121075116402962
- Mean Citation Score: 297.060654
- Max Citation Score: 317.0144
- Similarity Product: 198.3430601516724

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test